L-5-Hydroxytryptophan

CAT:
804-HY-B1716-01
Size:
100 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
L-5-Hydroxytryptophan - image 1

L-5-Hydroxytryptophan

  • UNSPSC Description:

    L-5-Hydroxytryptophan (L-5-HTP), a naturally occurring amino acid and a dietary supplement for use as an antidepressant, appetite suppressant, and sleep aid, is the immediate precursor of the neurotransmitter serotonin and a reserpine antagonist[1]. L-5-Hydroxytryptophan (L-5-HTP) is used to treat fibromyalgia, myoclonus, migraine, and cerebellar ataxia[2][3][4][5].
  • Target Antigen:

    Endogenous Metabolite
  • Type:

    Natural Products
  • Related Pathways:

    Metabolic Enzyme/Protease
  • Applications:

    Metabolism-protein/nucleotide metabolism
  • Field of Research:

    Metabolic Disease; Neurological Disease
  • Assay Protocol:

    https://www.medchemexpress.com/L-5-Hydroxytryptophan.html
  • Purity:

    99.90
  • Solubility:

    DMSO : 12.5 mg/mL (ultrasonic;warming;heat to 60°C)
  • Smiles:

    N[C@@H](CC1=CNC2=CC=C(O)C=C12)C(O)=O
  • Molecular Weight:

    220.228
  • References & Citations:

    [1]ARVID CARLSSON, et al. 3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists. Nature 180, page1200 (1957).|[2]Caruso I, et al. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res. 1990 May-Jun;18(3):201-9.|[3]Thal LJ, et al. Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations. Ann Neurol. 1980 Jun;7(6):570-6.|[4]Boiardi A, et al. 5-OH-Tryptophane in migraine: clinical and neurophysiological considerations. J Neurol. 1981;225(1):41-6.|[5]Trouillas P, et al. Improvement of cerebellar ataxia with levorotatory form of 5-hydroxytryptophan. A double-blind study with quantified data processing. Arch Neurol. 1988 Nov;45(11):1217-22.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Clinical Information:

    Launched
  • CAS Number:

    4350-09-8